- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Medicamen Biotech Limited — Updates, 21-02-2026: General Updates
21-02-2026 | 04:51 pm
21-02-2026 | 04:51 pm
Medicamen Biotech received a cautionary letter from NSE for secretarial audit observations. The company confirmed no impact on financials, operations, or other activities. This serves as an advisory for future compliance.
No comments yet. Be the first to comment!